vs

Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and EXPRO GROUP HOLDINGS N.V. (XPRO). Click either name above to swap in a different company.

EXPRO GROUP HOLDINGS N.V. is the larger business by last-quarter revenue ($382.1M vs $270.8M, roughly 1.4× HUTCHMED (China) Ltd). EXPRO GROUP HOLDINGS N.V. runs the higher net margin — 1.5% vs 0.7%, a 0.8% gap on every dollar of revenue. On growth, EXPRO GROUP HOLDINGS N.V. posted the faster year-over-year revenue change (-12.5% vs -16.5%). EXPRO GROUP HOLDINGS N.V. produced more free cash flow last quarter ($23.2M vs $3.4M).

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

Expro is an energy services provider headquartered in Houston, Texas, United States.

HCM vs XPRO — Head-to-Head

Bigger by revenue
XPRO
XPRO
1.4× larger
XPRO
$382.1M
$270.8M
HCM
Growing faster (revenue YoY)
XPRO
XPRO
+4.0% gap
XPRO
-12.5%
-16.5%
HCM
Higher net margin
XPRO
XPRO
0.8% more per $
XPRO
1.5%
0.7%
HCM
More free cash flow
XPRO
XPRO
$19.8M more FCF
XPRO
$23.2M
$3.4M
HCM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HCM
HCM
XPRO
XPRO
Revenue
$270.8M
$382.1M
Net Profit
$2.0M
$5.8M
Gross Margin
37.7%
Operating Margin
-13.2%
3.1%
Net Margin
0.7%
1.5%
Revenue YoY
-16.5%
-12.5%
Net Profit YoY
-83.6%
-74.9%
EPS (diluted)
$0.00
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCM
HCM
XPRO
XPRO
Q4 25
$270.8M
$382.1M
Q3 25
$411.4M
Q2 25
$277.7M
$422.7M
Q1 25
$324.5M
$390.9M
Q4 24
$436.8M
Q3 24
$422.8M
Q2 24
$305.7M
$469.6M
Q1 24
$383.5M
Net Profit
HCM
HCM
XPRO
XPRO
Q4 25
$2.0M
$5.8M
Q3 25
$14.0M
Q2 25
$455.0M
$18.0M
Q1 25
$11.9M
$13.9M
Q4 24
$23.0M
Q3 24
$16.3M
Q2 24
$25.8M
$15.3M
Q1 24
$-2.7M
Gross Margin
HCM
HCM
XPRO
XPRO
Q4 25
37.7%
Q3 25
Q2 25
0.1%
Q1 25
48.0%
Q4 24
Q3 24
Q2 24
41.1%
Q1 24
Operating Margin
HCM
HCM
XPRO
XPRO
Q4 25
-13.2%
3.1%
Q3 25
6.4%
Q2 25
-1.3%
7.7%
Q1 25
-5.0%
2.6%
Q4 24
7.3%
Q3 24
6.2%
Q2 24
-9.0%
5.9%
Q1 24
2.2%
Net Margin
HCM
HCM
XPRO
XPRO
Q4 25
0.7%
1.5%
Q3 25
3.4%
Q2 25
163.8%
4.3%
Q1 25
3.7%
3.6%
Q4 24
5.3%
Q3 24
3.8%
Q2 24
8.4%
3.3%
Q1 24
-0.7%
EPS (diluted)
HCM
HCM
XPRO
XPRO
Q4 25
$0.00
$0.05
Q3 25
$0.12
Q2 25
$0.52
$0.16
Q1 25
$0.01
$0.12
Q4 24
$0.20
Q3 24
$0.14
Q2 24
$0.03
$0.13
Q1 24
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCM
HCM
XPRO
XPRO
Cash + ST InvestmentsLiquidity on hand
$1.4B
$196.1M
Total DebtLower is stronger
$93.2M
$79.1M
Stockholders' EquityBook value
$1.2B
$1.5B
Total Assets
$1.8B
$2.3B
Debt / EquityLower = less leverage
0.08×
0.05×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCM
HCM
XPRO
XPRO
Q4 25
$1.4B
$196.1M
Q3 25
$197.9M
Q2 25
$1.4B
$206.8M
Q1 25
$836.1M
$179.3M
Q4 24
$183.0M
Q3 24
$165.7M
Q2 24
$802.5M
$133.5M
Q1 24
$163.2M
Total Debt
HCM
HCM
XPRO
XPRO
Q4 25
$93.2M
$79.1M
Q3 25
$99.1M
Q2 25
$93.4M
$121.1M
Q1 25
$82.8M
$121.1M
Q4 24
$121.1M
Q3 24
$121.1M
Q2 24
$82.1M
$121.1M
Q1 24
$40.0M
Stockholders' Equity
HCM
HCM
XPRO
XPRO
Q4 25
$1.2B
$1.5B
Q3 25
$1.5B
Q2 25
$1.2B
$1.5B
Q1 25
$759.9M
$1.5B
Q4 24
$1.5B
Q3 24
$1.5B
Q2 24
$740.1M
$1.5B
Q1 24
$1.3B
Total Assets
HCM
HCM
XPRO
XPRO
Q4 25
$1.8B
$2.3B
Q3 25
$2.3B
Q2 25
$1.8B
$2.3B
Q1 25
$1.3B
$2.3B
Q4 24
$2.3B
Q3 24
$2.3B
Q2 24
$1.3B
$2.3B
Q1 24
$2.0B
Debt / Equity
HCM
HCM
XPRO
XPRO
Q4 25
0.08×
0.05×
Q3 25
0.07×
Q2 25
0.08×
0.08×
Q1 25
0.11×
0.08×
Q4 24
0.08×
Q3 24
0.08×
Q2 24
0.11×
0.08×
Q1 24
0.03×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCM
HCM
XPRO
XPRO
Operating Cash FlowLast quarter
$8.2M
$57.1M
Free Cash FlowOCF − Capex
$3.4M
$23.2M
FCF MarginFCF / Revenue
1.2%
6.1%
Capex IntensityCapex / Revenue
1.8%
8.9%
Cash ConversionOCF / Net Profit
4.21×
9.89×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M
$97.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCM
HCM
XPRO
XPRO
Q4 25
$8.2M
$57.1M
Q3 25
$63.2M
Q2 25
$-72.9M
$48.4M
Q1 25
$40.3M
$41.5M
Q4 24
$97.4M
Q3 24
$55.3M
Q2 24
$-39.8M
$-13.2M
Q1 24
$29.9M
Free Cash Flow
HCM
HCM
XPRO
XPRO
Q4 25
$3.4M
$23.2M
Q3 25
$39.0M
Q2 25
$-82.2M
$27.2M
Q1 25
$32.5M
$8.4M
Q4 24
$53.0M
Q3 24
$23.3M
Q2 24
$-49.9M
$-49.5M
Q1 24
$-801.0K
FCF Margin
HCM
HCM
XPRO
XPRO
Q4 25
1.2%
6.1%
Q3 25
9.5%
Q2 25
-29.6%
6.4%
Q1 25
10.0%
2.1%
Q4 24
12.1%
Q3 24
5.5%
Q2 24
-16.3%
-10.5%
Q1 24
-0.2%
Capex Intensity
HCM
HCM
XPRO
XPRO
Q4 25
1.8%
8.9%
Q3 25
5.9%
Q2 25
3.3%
5.0%
Q1 25
2.4%
8.5%
Q4 24
10.2%
Q3 24
7.6%
Q2 24
3.3%
7.7%
Q1 24
8.0%
Cash Conversion
HCM
HCM
XPRO
XPRO
Q4 25
4.21×
9.89×
Q3 25
4.52×
Q2 25
-0.16×
2.69×
Q1 25
3.38×
2.98×
Q4 24
4.23×
Q3 24
3.40×
Q2 24
-1.54×
-0.86×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HCM
HCM

Segment breakdown not available.

XPRO
XPRO

NLA$130.3M34%
ESSA$116.3M30%
MENA$93.0M24%
Other$42.5M11%

Related Comparisons